DOUGLAS B. GIVEN - 27 Feb 2023 Form 4 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role
Director
Signature
/s/Douglass Given
Issuer symbol
ARWR
Transactions as of
27 Feb 2023
Net transactions value
-$28,542
Form type
4
Filing time
01 Mar 2023, 17:14:49 UTC
Previous filing
11 Jan 2023
Next filing
08 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARWR Common Stock Sale $28,542 -875 -6.3% $32.62 13,000 27 Feb 2023 By Trust F1
holding ARWR Common Stock 124,135 27 Feb 2023 Direct F2
holding ARWR Common Stock 12,500 27 Feb 2023 By Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities owned directly by Anne Given Trust ("AG Trust"). Mr. Given, as co-trustee of AG Trust, may be deemed to beneficially own the securities owned directly by AG Trust.
F2 Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.
F3 Represents securities owned directly by Katherine Given Ligtenberg Trust ("KGL Trust"). Mr. Given, as co-trustee of KGL Trust, may be deemed to beneficially own the securities owned directly by KGL Trust.